, Elash CA, Wright D. The VVSymQÒ instrument: use of a new patient-reported outcome measure for
assessment of varicose vein symptoms. Phlebology 2015;31:481-8.
54. Gibson K, Kabnick L; Varithena 013 Investigator G. A multicenter,
randomized, placebo-controlled study to evaluate the efﬁcacy and
safety of Varithena(R) (polidocanol endovenous microfoam 1%) for
symptomatic, visible varicose veins with saphenofemoral junction
incompetence. Phlebology 2017;32:185-93.
55. Wittens C, Davies AH, Baekgaard N, et al. Editor’s choice - management of chronic venous disease: clinical practice guidelines of
the European society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg 2015;49:678-737.
56. De Maeseneer MG, Kakkos SK, Aherne T, et al. Editor’s choice - European society for vascular surgery (ESVS) 2022 clinical practice

guidelines on the management of chronic venous disease of the
lower limbs. Eur J Vasc Endovasc Surg 2022;63:184-267.
57. Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic
venous disorders of the lower limbs. Guidelines According to Scientiﬁc Evidence. Part I. Int Angiol 2018;37:181-254.
58. Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic
venous disorders of the lower limbs. Guidelines According to Scientiﬁc Evidence. Part II. Int Angiol 2020;39:175-240.
59. Kursat Bozkurt A, Lawaetz M, Danielsson G, et al. European College
of Phlebology guideline for truncal ablation. Phlebology 2020;35:
73-83.
60